{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:22:55Z","timestamp":1785680575231,"version":"3.56.0"},"reference-count":222,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Context.<\/jats:italic>\n                    \u2014At present, Barrett esophagus is the most common cause of esophageal adenocarcinoma. In the past 20 years, the incidence of esophageal adenocarcinoma in white males has exceeded that of tumors of the colorectum, lung, prostate, and skin.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objectives.<\/jats:italic>\n                    \u2014To (1) provide an evidence-based review of the diagnosis, classification, and histologic differentiation of Barrett esophagus from gastric carditis, (2) provide a summary of the key pathologic features of precursor lesions, such as dysplasia, and (3) evaluate adjunctive markers of dysplasia and predictive markers for the development of cancer. The natural history and risk of cancer in patients with Barrett esophagus is also reviewed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Data Sources.<\/jats:italic>\n                    \u2014For this review, selected published peer reviewed articles were chosen from a search through PubMed between the years 1970 and 2007.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    \u2014The current definition of Barrett esophagus is partially flawed because not all cases are endoscopically recognizable, nongoblet epithelium is biologically intestinalized, and determination of the presence or absence of goblet cells is susceptible to sampling error. Differentiation of ultrashort segment Barrett esophagus from chronic gastric carditis can be accomplished, in a minority of cases, by evaluating for the presence or absence of histologic features that are known to be associated with Barrett esophagus. Dysplasia in Barrett esophagus begins in the crypt bases and then extends more superficially to include the upper portions of the crypts and surface epithelium. Low- and high-grade dysplasia are distinguished by the presence of marked cytologic and\/or architectural abnormalities in the latter compared with the former. There are few, if any, reliable adjunctive diagnostic techniques that can help differentiate nondysplastic from dysplastic epithelium. However, \u03b1-methylacyl coenzyme A racemase staining has been shown to be useful in 2 separate studies. Both low- and high-grade dysplasia are progressive lesions, and in general, the extent of dysplasia, particularly low grade, is a strong risk factor for progression to carcinoma. Of all the biologic and genetic biomarkers studied to date, evaluation of DNA content is the most reliable and specific. The management of patients with dysplasia is variable among institutions and ranges from aggressive surveillance, endoscopic mucosal resection, mucosal ablation, or total esophagectomy.\n                  <\/jats:p>","DOI":"10.5858\/2008-132-1577-uotdat","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T23:38:04Z","timestamp":1613086684000},"page":"1577-1585","source":"Crossref","is-referenced-by-count":37,"title":["Update on the Diagnosis and Treatment of Barrett Esophagus and Related Neoplastic Precursor Lesions"],"prefix":"10.5858","volume":"132","author":[{"given":"Robert D.","family":"Odze","sequence":"first","affiliation":[{"name":"From the GI Pathology Service, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"i1543-2165-132-10-1577-b1","series-title":"Cancer","first-page":"676","article-title":"Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.","volume":"3","author":"Wild, C. P.","year":"2003","unstructured":"Wild, C. P. and L. J.Hardle. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.Cancer2003. 3:676\u2013684."},{"key":"i1543-2165-132-10-1577-b2","series-title":"Scand J Gastroenterol","first-page":"51","article-title":"Barrett's oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues.","volume":"35","author":"van Sandick, J. W.","year":"2001","unstructured":"van Sandick, J. W., J. J. B.van Lanschot, G. N. J.Tygat, G. J. A.Offerhaus, and H.Obertop. Barrett's oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues.Scand J Gastroenterol2001. 35:51\u201360."},{"key":"i1543-2165-132-10-1577-b3","series-title":"Int J Cancer","first-page":"860","article-title":"Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995.","volume":"99","author":"Vizcaino, A. P.","year":"2002","unstructured":"Vizcaino, A. P., V.Moreno, R.Lambert, and D. M.Perkin. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995.Int J Cancer2002. 99:860\u2013868."},{"key":"i1543-2165-132-10-1577-b4","series-title":"Cancer","first-page":"2049","article-title":"Changing patterns in the incidence of esophageal and gastric carcinomas in the United States.","volume":"3","author":"Devesa, S. S.","year":"1988","unstructured":"Devesa, S. S., W. J.Blot, and J. F.Fraumeni. Changing patterns in the incidence of esophageal and gastric carcinomas in the United States.Cancer1988. 3:2049\u20132053."},{"key":"i1543-2165-132-10-1577-b5","series-title":"Int J Epidemiol","first-page":"645","article-title":"Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.","volume":"29","author":"Botterweck, A. A. M.","year":"2000","unstructured":"Botterweck, A. A. M., L. J.Schouten, and A.Volovics. et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.Int J Epidemiol2000. 29:645\u2013654."},{"key":"i1543-2165-132-10-1577-b6","series-title":"Gastroenterology","first-page":"310","article-title":"A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.","volume":"127","author":"Sharma, P.","year":"2004","unstructured":"Sharma, P., K.McQuaid, and J.Dent. et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.Gastroenterology2004. 127:310\u2013330."},{"key":"i1543-2165-132-10-1577-b7","series-title":"Gastroenterology","first-page":"461","article-title":"Prevalence of Barrett's esophagus in asymptomatic individuals.","volume":"123","author":"Gerson, L. B.","year":"2002","unstructured":"Gerson, L. B., K.Shelter, and G.Triadafilopoulos. Prevalence of Barrett's esophagus in asymptomatic individuals.Gastroenterology2002. 123:461\u2013467."},{"key":"i1543-2165-132-10-1577-b8","series-title":"Gastroenterology","first-page":"1670","article-title":"Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.","volume":"125","author":"Rex, D. K.","year":"2003","unstructured":"Rex, D. K., O'W.Cummings, and M.Shaw. et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.Gastroenterology2003. 125:1670\u20131677."},{"issue":"1","key":"i1543-2165-132-10-1577-b9","series-title":"Cancer Cell","first-page":"11","article-title":"Focus on Barrett's esophagus and esophageal adenocarcinoma.","volume":"6","author":"Paulson, T. G.","year":"2004","unstructured":"Paulson, T. G. and B. J.Reid. Focus on Barrett's esophagus and esophageal adenocarcinoma.Cancer Cell2004. 61:11\u201316."},{"key":"i1543-2165-132-10-1577-b10","series-title":"Mod Pathol","first-page":"614","article-title":"The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventative strategies in Barrett's esophagus.","volume":"13","author":"Ormsby, A. H.","year":"2000","unstructured":"Ormsby, A. H., S. P.Kilgore, J. R.Goldblum, J. E.Richter, T. W.Rice, and T. L.Gramlich. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventative strategies in Barrett's esophagus.Mod Pathol2000. 13:614\u2013620."},{"key":"i1543-2165-132-10-1577-b11","series-title":"CA Cancer J Clin","first-page":"334","article-title":"Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.","volume":"55","author":"Souza, R. F.","year":"2005","unstructured":"Souza, R. F. and S. J.Spechler. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.CA Cancer J Clin2005. 55:334\u2013351."},{"key":"i1543-2165-132-10-1577-b12","series-title":"Gastroenterology","first-page":"1246","article-title":"Barrett's esophagus: development of dysplasia and adenocarcinoma.","volume":"96","author":"Hameetemen, W.","year":"1989","unstructured":"Hameetemen, W., G. N. J.Tytgat, H. J.Houthoff, and J. G.van den Tweel. Barrett's esophagus: development of dysplasia and adenocarcinoma.Gastroenterology1989. 96:1246\u20131256."},{"key":"i1543-2165-132-10-1577-b13","series-title":"Gastroenterology","first-page":"277","article-title":"Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.","volume":"116","author":"Hirota, W. K.","year":"1999","unstructured":"Hirota, W. K., T. N.Loughney, D. J.Lazas, C. L.Maydonovitch, V.Rholl, and R. K.Wong. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.Gastroenterology1999. 116:277\u2013285."},{"key":"i1543-2165-132-10-1577-b14","series-title":"Am J Gastroenterol","first-page":"788","article-title":"Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus.","volume":"103","year":"2008","unstructured":"Practice Parameters Committee of the American College of Gastroenterology.\n          \n          Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus.\n          Am J Gastroenterol\n          2008. 103:788\u2013797."},{"key":"i1543-2165-132-10-1577-b15","series-title":"Dig Dis Sci","first-page":"1537","article-title":"Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.","volume":"48","author":"Gopal, D. V.","year":"2003","unstructured":"Gopal, D. V., D. A.Lieberman, and N.Margaret. et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.Dig Dis Sci2003. 48:1537\u20131541."},{"key":"i1543-2165-132-10-1577-b16","series-title":"Am J Gastroenterol","first-page":"1930","article-title":"Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.","volume":"97","author":"Avidan, B.","year":"2002","unstructured":"Avidan, B., A.Sonnenberg, T. G.Schnell, G.Chejfec, A.Metz, and S. J.Sontag. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.Am J Gastroenterol2002. 97:1930\u20131936."},{"key":"i1543-2165-132-10-1577-b17","series-title":"Gastroenterology","first-page":"1212","article-title":"Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometry follow-up of a cohort.","volume":"102","author":"Reid, B. J.","year":"1992","unstructured":"Reid, B. J., P. L.Blount, C. E.Rubin, D. S.Levine, R. C.Haggitt, and P. S.Rabinovitch. Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometry follow-up of a cohort.Gastroenterology1992. 102:1212\u20131219."},{"key":"i1543-2165-132-10-1577-b18","series-title":"Gastroenterology","first-page":"1392","article-title":"The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M Criteria.","volume":"131","author":"Sharma, P.","year":"2006","unstructured":"Sharma, P., J.Dent, and D.Armstrong. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M Criteria.Gastroenterology2006. 131:1392\u20131399."},{"key":"i1543-2165-132-10-1577-b19","series-title":"Am J Surg Pathol","first-page":"183","article-title":"Surgical pathology of adenocarcinoma arising in Barrett's esophagus: analysis of 67 cases.","volume":"19","author":"Paraf, F.","year":"1995","unstructured":"Paraf, F., J. F.Flejou, and J. P.Pignon. et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus: analysis of 67 cases.Am J Surg Pathol1995. 19:183\u2013191."},{"key":"i1543-2165-132-10-1577-b20","series-title":"Am J Surg Pathol","first-page":"563","article-title":"The spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of 26 patients.","volume":"8","author":"Smith, R. R.","year":"1984","unstructured":"Smith, R. R., S. R.Hamilton, and J. K.Boitnott. et al. The spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of 26 patients.Am J Surg Pathol1984. 8:563\u2013573."},{"key":"i1543-2165-132-10-1577-b21","series-title":"Am J Gastroenterol","first-page":"1853","article-title":"Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.","volume":"100","author":"Odze, R. D.","year":"2005","unstructured":"Odze, R. D.\n          \n          Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.\n          Am J Gastroenterol\n          2005. 100:1853\u20131867."},{"key":"i1543-2165-132-10-1577-b22","series-title":"Am J Surg Pathol","first-page":"1442","article-title":"Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.","volume":"27","author":"Philips, R. W.","year":"2003","unstructured":"Philips, R. W., H. F.Frierson, and C. A.Moskaluk. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.Am J Surg Pathol2003. 27:1442\u20131447."},{"key":"i1543-2165-132-10-1577-b23","series-title":"Am J Surg Pathol","first-page":"978","article-title":"Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to CEA, CD10 and AFP.","volume":"26","author":"Chu, P. G.","year":"2002","unstructured":"Chu, P. G., S.Ishizawa, and E.Wu. et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to CEA, CD10 and AFP.Am J Surg Pathol2002. 26:978\u2013988."},{"key":"i1543-2165-132-10-1577-b24","series-title":"Biochem Cell Biol","first-page":"957","article-title":"Cdx1 and Cdx2 homeobox genes in the intestine.","volume":"7","author":"Freund, J. N.","year":"1998","unstructured":"Freund, J. N., C.Domon-Dell, and M.Kedinger. et al. Cdx1 and Cdx2 homeobox genes in the intestine.Biochem Cell Biol1998. 7:957\u2013969."},{"key":"i1543-2165-132-10-1577-b25","series-title":"Am J Surg Pathol","first-page":"1357","article-title":"Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.","volume":"27","author":"Glickman, J. N.","year":"2003","unstructured":"Glickman, J. N., A.Shahsafaei, and R. D.Odze. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.Am J Surg Pathol2003. 27:1357\u20131365."},{"key":"i1543-2165-132-10-1577-b26","series-title":"Am J Gastroenterol","first-page":"1375","article-title":"Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.","volume":"97","author":"Cameron, A. J.","year":"2002","unstructured":"Cameron, A. J., E. O.Souto, and T. C.Smyrk. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.Am J Gastroenterol2002. 97:1375\u20131380."},{"key":"i1543-2165-132-10-1577-b27","series-title":"Dis Esophagus","first-page":"287","article-title":"Adenocarcinoma of the esophagogastric junction: could the characteristics of adjacent intestinal metaplasia help in the understanding of biopathogenesis.","volume":"15","author":"Cabrera, R. A.","year":"2002","unstructured":"Cabrera, R. A., P.Chaves, and M.Crespo. et al. Adenocarcinoma of the esophagogastric junction: could the characteristics of adjacent intestinal metaplasia help in the understanding of biopathogenesis.Dis Esophagus2002. 15:287\u2013289."},{"key":"i1543-2165-132-10-1577-b28","series-title":"Gastroenterology","first-page":"264A","article-title":"Loss of goblet cell differentiation occurs with the progression of dysplasia in Barrett's esophagus.","volume":"130","author":"Srivastava, A.","year":"2006","unstructured":"Srivastava, A., J. L.Hornick, and X.Li. et al. Loss of goblet cell differentiation occurs with the progression of dysplasia in Barrett's esophagus.Gastroenterology2006. 130:(suppl 2). 264A."},{"key":"i1543-2165-132-10-1577-b29","series-title":"Dig Dis Sci","first-page":"2108","article-title":"Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy.","volume":"47","author":"Jones, T. F.","year":"2002","unstructured":"Jones, T. F., P.Sharma, and B.Daaboul. et al. Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy.Dig Dis Sci2002. 47:2108\u20132111."},{"key":"i1543-2165-132-10-1577-b30","series-title":"Am J Gastroenterol","first-page":"115","article-title":"Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.","volume":"102","author":"Harrison, R.","year":"2007","unstructured":"Harrison, R., I.Perry, and W.Haddadin. et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.Am J Gastroenterol2007. 102:115\u20131161."},{"key":"i1543-2165-132-10-1577-b31","series-title":"Ann Surg","first-page":"619","article-title":"Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.","volume":"234","author":"Oberg, S.","year":"2001","unstructured":"Oberg, S., J.Johansson, and J.Wenner. et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.Ann Surg2001. 234:619\u2013626."},{"key":"i1543-2165-132-10-1577-b32","series-title":"Lancet","first-page":"1711","article-title":"Cytokerin 7\/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia?","volume":"33","author":"Odze, R.","year":"2002","unstructured":"Odze, R.\n          \n          Cytokerin 7\/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia?\n          Lancet\n          2002. 33:1711\u20131713."},{"issue":"1","key":"i1543-2165-132-10-1577-b33","series-title":"Ann Diag Pathol","first-page":"67","article-title":"The significance and etiology of intestinal metaplasia of the esophagogastric junction.","volume":"61","author":"Goldblum, J. R.","year":"2002","unstructured":"Goldblum, J. R.\n          \n          The significance and etiology of intestinal metaplasia of the esophagogastric junction.\n          Ann Diag Pathol\n          2002. 611:67\u201373."},{"key":"i1543-2165-132-10-1577-b34","series-title":"Gastroenterology","first-page":"218","article-title":"The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.","volume":"117","author":"Spechler, S. J.","year":"1999","unstructured":"Spechler, S. J.\n          \n          The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.\n          Gastroenterology\n          1999. 117:218\u2013228."},{"key":"i1543-2165-132-10-1577-b35","series-title":"Am J Surg Pathol","first-page":"1733","article-title":"Morphological features are useful in distinguishing Barrett's esophagus from carditis with intestinal metaplasia.","volume":"31","author":"Srivastava, A.","year":"2007","unstructured":"Srivastava, A., R. D.Odze, G.Lauwers, M.Redston, D.Antonioli, and J. N.Glickman. Morphological features are useful in distinguishing Barrett's esophagus from carditis with intestinal metaplasia.Am J Surg Pathol2007. 31:1733\u20131741."},{"key":"i1543-2165-132-10-1577-b36","series-title":"Am J Surg Pathol","first-page":"960","article-title":"Pathologic features of reflux and Helicobacter pylori-associated carditis; a comparative study.","volume":"27","author":"Wieczorek, T.","year":"2003","unstructured":"Wieczorek, T., H.Wang, D.Antonioli, J.Glickman, and R.Odze. Pathologic features of reflux and Helicobacter pylori-associated carditis; a comparative study.Am J Surg Pathol2003. 27:960\u2013968."},{"key":"i1543-2165-132-10-1577-b37","series-title":"Hum Pathol","first-page":"1","article-title":"Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction.","volume":"30","author":"Chen, Y.","year":"1999","unstructured":"Chen, Y., H. H.Wang, and D. A.Antonioli. et al. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction.Hum Pathol1999. 30:1\u20138."},{"key":"i1543-2165-132-10-1577-b38","series-title":"Am J Surg Pathol","first-page":"1357","article-title":"The mucin core polypeptide pattern can help distinguish Barrett's esophagus (BE) from inflammation of the gastric cardia (carditis) with intestinal metaplasia.","volume":"27","author":"Glickman, J. N.","year":"2003","unstructured":"Glickman, J. N., A.Shahsafaei, and R. D.Odze. The mucin core polypeptide pattern can help distinguish Barrett's esophagus (BE) from inflammation of the gastric cardia (carditis) with intestinal metaplasia.Am J Surg Pathol2003. 27:1357\u20131365."},{"key":"i1543-2165-132-10-1577-b39","series-title":"Hum Pathol","first-page":"288","article-title":"Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.","volume":"30","author":"Ormsby, A. H.","year":"1999","unstructured":"Ormsby, A. H., J. R.Goldblum, and T. W.Rice. et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.Hum Pathol1999. 30:288\u2013294."},{"key":"i1543-2165-132-10-1577-b40","series-title":"Gastroenterology","first-page":"415A","article-title":"Interinstitutional variability in the interpretation of cytokeratin 7\/20 staining patterns in Barrett's esophagus.","volume":"120","author":"Glickman, J. N.","year":"2001","unstructured":"Glickman, J. N., A. H.Ormsby, T.Gramlich, J. R.Goldblum, and R. D.Odze. Interinstitutional variability in the interpretation of cytokeratin 7\/20 staining patterns in Barrett's esophagus.Gastroenterology2001. 120:415A."},{"key":"i1543-2165-132-10-1577-b41","series-title":"Mod Pathol","first-page":"611","article-title":"Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.","volume":"15","author":"Mohammed, I. A.","year":"2002","unstructured":"Mohammed, I. A., C. J.Streutker, and R. H.Riddell. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.Mod Pathol2002. 15:611\u2013616."},{"key":"i1543-2165-132-10-1577-b42","series-title":"Am J Gastroenterol","first-page":"1378","article-title":"Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.","volume":"96","author":"El-Zimaity, H. M. T.","year":"2001","unstructured":"El-Zimaity, H. M. T. and D. Y.Graham. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.Am J Gastroenterol2001. 96:1378\u20131382."},{"key":"i1543-2165-132-10-1577-b43","article-title":"Pathogenesis of columnar cell-lined (Barrett's) esophagus.","author":"Hamilton, S. R.","unstructured":"Hamilton, S. R.\n          \n          Pathogenesis of columnar cell-lined (Barrett's) esophagus.\n          In: Spechler SJ, Goyal RK, eds. Barrett's Esophagus. New York, NY: Elsevier; 1985: 29\u201337."},{"key":"i1543-2165-132-10-1577-b44","series-title":"Am J Surg Pathol","first-page":"344","article-title":"Definition of histopathologic changes in gastroesophageal reflux disease.","volume":"24","author":"Chandrasoma, P. T.","year":"2000","unstructured":"Chandrasoma, P. T., D. M.Lokuhetty, and T. R.DeMeester. et al. Definition of histopathologic changes in gastroesophageal reflux disease.Am J Surg Pathol2000. 24:344\u2013351."},{"key":"i1543-2165-132-10-1577-b45","series-title":"Am J Gastroenterol","first-page":"2514","article-title":"Cytokeratin and DAS-1 immunostaining reveal similarities among the cardiac mucosa, CIM and Barrett's esophagus.","volume":"97","author":"DeMeester, S. R.","year":"2002","unstructured":"DeMeester, S. R., K. S.Wickramasinghe, and R. V. N.Lord. et al. Cytokeratin and DAS-1 immunostaining reveal similarities among the cardiac mucosa, CIM and Barrett's esophagus.Am J Gastroenterol2002. 97:2514\u20132523."},{"key":"i1543-2165-132-10-1577-b46","series-title":"Science","first-page":"1568","article-title":"Gastric cancer originating from bone marrow-derived cells.","volume":"306","author":"Houghton, J. M.","year":"2004","unstructured":"Houghton, J. M., C.Stoicov, and S.Nomura. et al. Gastric cancer originating from bone marrow-derived cells.Science2004. 306:1568\u20131571."},{"key":"i1543-2165-132-10-1577-b47","series-title":"Curr Opin Cell Biol","first-page":"740","article-title":"Epithelial-mesenchymal transitions in development and pathologies.","volume":"15","author":"Thiery, J. P.","year":"2003","unstructured":"Thiery, J. P.\n          \n          Epithelial-mesenchymal transitions in development and pathologies.\n          Curr Opin Cell Biol\n          2003. 15:740\u2013746."},{"key":"i1543-2165-132-10-1577-b48","series-title":"Br J Surg","first-page":"113","article-title":"Experimental columnar metaplasia in the canine oesophagus.","volume":"75","author":"Gillen, P.","year":"1988","unstructured":"Gillen, P., P.Keeling, P. J.Byrne, A. B.West, and T. P.Hennessy. Experimental columnar metaplasia in the canine oesophagus.Br J Surg1988. 75:113\u2013115."},{"key":"i1543-2165-132-10-1577-b49","series-title":"Surgery","first-page":"17","article-title":"Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus.","volume":"115","author":"Li, H.","year":"1994","unstructured":"Li, H., T. N.Walsh, and G.O'Dowd. et al. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus.Surgery1994. 115:17\u201381."},{"key":"i1543-2165-132-10-1577-b50","series-title":"J Thorac Cardiovasc Surg","first-page":"13","article-title":"The lower esophagus lined by columnar epithelium: its association with hiatal hernia, ulcer stricture, and tumor.","volume":"45","author":"Adler, R. H.","year":"1963","unstructured":"Adler, R. H.\n          \n          The lower esophagus lined by columnar epithelium: its association with hiatal hernia, ulcer stricture, and tumor.\n          J Thorac Cardiovasc Surg\n          1963. 45:13\u201332."},{"key":"i1543-2165-132-10-1577-b51","series-title":"Am J Surg Pathol","first-page":"569","article-title":"Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus.","volume":"25","author":"Glickman, J. N.","year":"2001","unstructured":"Glickman, J. N., Y. Y.Chen, and H. H.Wang. et al. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus.Am J Surg Pathol2001. 25:569\u2013578."},{"key":"i1543-2165-132-10-1577-b52","series-title":"Am J Gastroenterol","first-page":"3268","article-title":"Prospective evaluation of multilayered epithelium in Barrett's esophagus.","volume":"96","author":"Shields, H.","year":"201","unstructured":"Shields, H., S. J.Rosenberg, and F. R.Zwas. et al. Prospective evaluation of multilayered epithelium in Barrett's esophagus.Am J Gastroenterol201. 96:3268\u20133273."},{"key":"i1543-2165-132-10-1577-b53","series-title":"Mod Pathol","first-page":"103A","article-title":"Multilayered epithelium at the squamocolumnar junction is a histological marker for gastroesophageal reflux disease.","volume":"81","author":"Glickman, J. N.","year":"2005","unstructured":"Glickman, J. N., S. J.Spechler, and T.Dineen. et al. Multilayered epithelium at the squamocolumnar junction is a histological marker for gastroesophageal reflux disease.Mod Pathol2005. 81:(suppl 1). 103A."},{"key":"i1543-2165-132-10-1577-b54","series-title":"J Clin Pathol","first-page":"1029","article-title":"Diagnosis and grading of dysplasia in Barrett's oesophagus.","volume":"59","author":"Odze, R. D.","year":"2006","unstructured":"Odze, R. D.\n          \n          Diagnosis and grading of dysplasia in Barrett's oesophagus.\n          J Clin Pathol\n          2006. 59:1029\u20131038."},{"key":"i1543-2165-132-10-1577-b55","series-title":"Hum Pathol","first-page":"931","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical information.","volume":"14","author":"Riddell, R. H.","year":"1983","unstructured":"Riddell, R. H., H.Goldman, and D. E.Ransohoff. et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical information.Hum Pathol1983. 14:931\u2013968."},{"key":"i1543-2165-132-10-1577-b56","series-title":"Gastroenterology","first-page":"1606","article-title":"Long-term surgical management of Barrett's esophagus with high-grade dysplasia.","volume":"120","author":"Schnell, T. G.","year":"2001","unstructured":"Schnell, T. G., S. J.Sontag, and G.Chejfec. et al. Long-term surgical management of Barrett's esophagus with high-grade dysplasia.Gastroenterology2001. 120:1606\u20131619."},{"key":"i1543-2165-132-10-1577-b57","series-title":"Gut","first-page":"251","article-title":"The Vienna classification of gastrointestinal epithelial neoplasia.","volume":"47","author":"Schlemper, R. J.","year":"200","unstructured":"Schlemper, R. J., R. H.Riddell, and Y.Kato. et al. The Vienna classification of gastrointestinal epithelial neoplasia.Gut200. 47:251\u2013255."},{"key":"i1543-2165-132-10-1577-b58","series-title":"Nat Genet","first-page":"106","article-title":"Evolution of neoplastic cell lineages in Barrett's oesophagus.","volume":"22","author":"Barrett, M. T.","year":"1999","unstructured":"Barrett, M. T., C. A.Sanchez, and L. J.Prevo. et al. Evolution of neoplastic cell lineages in Barrett's oesophagus.Nat Genet1999. 22:106\u2013109."},{"key":"i1543-2165-132-10-1577-b59","series-title":"Nat Genet","first-page":"468","article-title":"Genetic clonal diversity predicts progression to esophageal adenocarcinoma.","volume":"38","author":"Maley, C. C.","year":"2006","unstructured":"Maley, C. C., P. C.Galipeau, and J. C.Finley. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma.Nat Genet2006. 38:468\u2013473."},{"key":"i1543-2165-132-10-1577-b60","series-title":"Semin Cancer Biol","first-page":"474","article-title":"Natural selection in neoplastic progression of Barrett's esophagus.","volume":"15","author":"Maley, C. C.","year":"2005","unstructured":"Maley, C. C. and B. J.Reid. Natural selection in neoplastic progression of Barrett's esophagus.Semin Cancer Biol2005. 15:474\u2013483."},{"key":"i1543-2165-132-10-1577-b61","series-title":"Can Res","first-page":"3414","article-title":"Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.","volume":"64","author":"Maley, C. C.","year":"2004","unstructured":"Maley, C. C., P. C.Galipeau, and X.Li. et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.Can Res2004. 64:3414\u20133427."},{"key":"i1543-2165-132-10-1577-b62","series-title":"Hum Pathol","first-page":"412","article-title":"Proliferative characteristics of intestinalized mucosa win the distal esophagus and gastroesophageal junction (short segment Barrett's esophagus).","volume":"30","author":"Gulizia, J.","year":"1999","unstructured":"Gulizia, J., H.Wang, and D.Antonioli. et al. Proliferative characteristics of intestinalized mucosa win the distal esophagus and gastroesophageal junction (short segment Barrett's esophagus).Hum Pathol1999. 30:412\u2013419."},{"key":"i1543-2165-132-10-1577-b63","series-title":"Cancer Res","first-page":"8284","article-title":"p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.","volume":"61","author":"Wong, D. J.","year":"2001","unstructured":"Wong, D. J., T. G.Paulon, and L. J.Prevo. et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.Cancer Res2001. 61:8284\u20138289."},{"key":"i1543-2165-132-10-1577-b64","series-title":"Mod Pathol","first-page":"788","article-title":"Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved.","volume":"20","author":"Chaves, P.","year":"2007","unstructured":"Chaves, P., M.Crespo, and C.Ribeiro. et al. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved.Mod Pathol2007. 20:788\u2013796."},{"key":"i1543-2165-132-10-1577-b65","series-title":"Lab Invest","first-page":"466","article-title":"High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.","volume":"87","author":"Yu, C.","year":"2007","unstructured":"Yu, C., X.Zhang, and Q.Huang. et al. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.Lab Invest2007. 87:466\u2013472."},{"key":"i1543-2165-132-10-1577-b66","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"559","article-title":"p53 is frequently mutated in Barrett's metaplasia of the intestinal type.","volume":"5","author":"Campomenosi, P.","year":"1996","unstructured":"Campomenosi, P., M.Conio, and M.Bogliolo. et al. p53 is frequently mutated in Barrett's metaplasia of the intestinal type.Cancer Epidemiol Biomarkers Prev1996. 5:559\u2013565."},{"key":"i1543-2165-132-10-1577-b67","series-title":"Hum Pathol","first-page":"368","article-title":"Reproducibility of the diagnosis if dysplasia in Barrett's esophagus: a reaffirmation.","volume":"32","author":"Montgomery, E.","year":"2001","unstructured":"Montgomery, E., M. P.Bronner, and J. R.Goldblum. et al. Reproducibility of the diagnosis if dysplasia in Barrett's esophagus: a reaffirmation.Hum Pathol2001. 32:368\u2013378."},{"key":"i1543-2165-132-10-1577-b68","series-title":"Hum Pathol","first-page":"166","article-title":"Observer variation in the diagnosis of dysplasia in Barrett's esophagus.","volume":"19","author":"Reid, B. J.","year":"1988","unstructured":"Reid, B. J., R. C.Haggitt, and C. E.Rubin. et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.Hum Pathol1988. 19:166\u2013178."},{"key":"i1543-2165-132-10-1577-b69","series-title":"Histopathology","first-page":"920","article-title":"Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.","volume":"50","author":"Kerkhof, M.","year":"2007","unstructured":"Kerkhof, M., H.van Dekken, and E. W.Steyerberg. et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.Histopathology2007. 50:920\u2013927."},{"key":"i1543-2165-132-10-1577-b70","series-title":"Am J Surg Pathol","first-page":"423","article-title":"Crypt dysplasia with surface maturation: a clinical, pathologic and molecular study of a Barrett's esophagus cohort.","volume":"30","author":"Lomo, L.","year":"2006","unstructured":"Lomo, L., P. L.Blount, and C. A.Sanchez. et al. Crypt dysplasia with surface maturation: a clinical, pathologic and molecular study of a Barrett's esophagus cohort.Am J Surg Pathol2006. 30:423\u2013435."},{"key":"i1543-2165-132-10-1577-b71","series-title":"Lab Invest","first-page":"133A","article-title":"High fidelity image cytometry in neoplastic lesions in Barrett's esophagus, including basal crypt dysplasia-like atypia with surface maturation.","volume":"87","author":"Zhang, X.","year":"2007","unstructured":"Zhang, X., R.Goyal, Q.Huang, and RdOdze. High fidelity image cytometry in neoplastic lesions in Barrett's esophagus, including basal crypt dysplasia-like atypia with surface maturation.Lab Invest2007. 87:(suppl 1). 133A."},{"key":"i1543-2165-132-10-1577-b72","series-title":"Ann Thorac Surg","first-page":"787","article-title":"Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.","volume":"65","author":"Rice, T. W.","year":"1998","unstructured":"Rice, T. W., G. JrZuccaro, and D. J.Adelstein. et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.Ann Thorac Surg1998. 65:787\u2013792."},{"key":"i1543-2165-132-10-1577-b73","series-title":"Gut","first-page":"671","article-title":"Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.","volume":"51","author":"Ormsby, A. H.","year":"2002","unstructured":"Ormsby, A. H., R. I.Petros, and W. H.Henricks. et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.Gut2002. 51:671\u2013676."},{"key":"i1543-2165-132-10-1577-b74","series-title":"Cancer","first-page":"423","article-title":"Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.","volume":"75","author":"Hong, M. K.","year":"1995","unstructured":"Hong, M. K., W. B.Laskin, and B. E.Herman. et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.Cancer1995. 75:423\u2013429."},{"key":"i1543-2165-132-10-1577-b75","series-title":"Dis Esophagus","first-page":"322","article-title":"Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.","volume":"17","author":"Feith, M.","year":"2004","unstructured":"Feith, M., H. J.Stein, and J.Mueller. et al. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.Dis Esophagus2004. 17:322\u2013327."},{"key":"i1543-2165-132-10-1577-b76","series-title":"J Natl Cancer Inst","first-page":"1316","article-title":"Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.","volume":"92","author":"Bani-Hani, K.","year":"200","unstructured":"Bani-Hani, K., I. G.Martin, and L. J.Hardie. et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.J Natl Cancer Inst200. 92:1316\u20131321."},{"key":"i1543-2165-132-10-1577-b77","series-title":"Ann Surg","first-page":"17","article-title":"Barrett's esophagus: the significance of p53 in clinical practice.","volume":"225","author":"Ireland, A. P.","year":"1997","unstructured":"Ireland, A. P., G. W. B.Clark, and T. R.DeMeester. Barrett's esophagus: the significance of p53 in clinical practice.Ann Surg1997. 225:17\u201330."},{"key":"i1543-2165-132-10-1577-b78","series-title":"Gastroenterology","first-page":"1220","article-title":"Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.","volume":"102","author":"Ramel, S.","year":"1992","unstructured":"Ramel, S., B. J.Reid, and C. A.Sanchez. et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.Gastroenterology1992. 102:1220\u20131228."},{"key":"i1543-2165-132-10-1577-b79","series-title":"Am J Surg Pathol","first-page":"871","article-title":"AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis and Crohn's disease.","volume":"30","author":"Dorer, R.","year":"2006","unstructured":"Dorer, R. and R. D.Odze. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis and Crohn's disease.Am J Surg Pathol2006. 30:871\u2013877."},{"key":"i1543-2165-132-10-1577-b80","series-title":"Hum Pathol","first-page":"1601","article-title":"Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.","volume":"37","author":"Lisovsky, M.","year":"2006","unstructured":"Lisovsky, M., O.Falkowski, and T.Bhuiya. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.Hum Pathol2006. 37:1601\u20131606."},{"key":"i1543-2165-132-10-1577-b81","series-title":"Am J Gastroenterol","first-page":"1657","article-title":"Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.","volume":"99","author":"Weston, A. P.","year":"2004","unstructured":"Weston, A. P., P.Sharma, and S.Mathur. et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.Am J Gastroenterol2004. 99:1657\u20131666."},{"key":"i1543-2165-132-10-1577-b82","series-title":"Am J Gastroenterol","first-page":"1669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.","volume":"95","author":"Reid, B. J.","year":"2000","unstructured":"Reid, B. J., D. S.Levine, and G.Longton. et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.Am J Gastroenterol2000. 95:1669\u20131676."},{"key":"i1543-2165-132-10-1577-b83","series-title":"Gastroenterology","first-page":"1630","article-title":"Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.","volume":"120","author":"Buttar, N. S.","year":"2001","unstructured":"Buttar, N. S., K. K.Wang, and T. J.Sebo. et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.Gastroenterology2001. 120:1630\u20131639."},{"key":"i1543-2165-132-10-1577-b84","series-title":"Am J Gastroenterol","first-page":"27","article-title":"Are ulcers a marker for invasive carcinoma in Barrett's esophagus?: data from a diagnostic variability study with clinical follow-up.","volume":"97","author":"Montgomery, E.","year":"2002","unstructured":"Montgomery, E., M. P.Bronner, and J. K.Greenson. et al. Are ulcers a marker for invasive carcinoma in Barrett's esophagus?: data from a diagnostic variability study with clinical follow-up.Am J Gastroenterol2002. 97:27\u201331."},{"key":"i1543-2165-132-10-1577-b85","series-title":"Am J Gastroenterol","first-page":"1888","article-title":"Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.","volume":"97","author":"Sampler, R. E.","year":"2002","unstructured":"Sampler, R. E.\n          \n          Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.\n          Am J Gastroenterol\n          2002. 97:1888\u20131895."},{"key":"i1543-2165-132-10-1577-b86","series-title":"Am J Gastroenterol","first-page":"1355","article-title":"p53 protein over expression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.","volume":"96","author":"Weston, A. P.","year":"2001","unstructured":"Weston, A. P., S. K.Banerjee, P.Sharma, T. M.Tran, R.Richards, and R.Cherian. p53 protein over expression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.Am J Gastroenterol2001. 96:1355\u20131362."},{"key":"i1543-2165-132-10-1577-b87","series-title":"Clin Gastroenterol Hepatol","first-page":"566","article-title":"Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.","volume":"4","author":"Sharma, P.","year":"2006","unstructured":"Sharma, P., G. W.Falk, and A. P.Weston. et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.Clin Gastroenterol Hepatol2006. 4:566\u2013572."},{"key":"i1543-2165-132-10-1577-b88","series-title":"Am J Gastroenterol","first-page":"1931","article-title":"Long-term endoscopic surveillance of patients with Barrett's esophagus: incidence of dysplasia and adenocarcinoma: a prospective study.","volume":"98","author":"Conio, M.","year":"2003","unstructured":"Conio, M., S.Blanchi, and G.Lapertoso. et al. Long-term endoscopic surveillance of patients with Barrett's esophagus: incidence of dysplasia and adenocarcinoma: a prospective study.Am J Gastroenterol2003. 98:1931\u20131939."},{"key":"i1543-2165-132-10-1577-b89","series-title":"Am J Gastroenterol","first-page":"483","article-title":"Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.","volume":"102","author":"Srivastava, A.","year":"2007","unstructured":"Srivastava, A., J. L.Hornick, and X.Li. et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.Am J Gastroenterol2007. 102:483\u2013493."},{"key":"i1543-2165-132-10-1577-b90","series-title":"Am J Gastroenterol","first-page":"3383","article-title":"The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.","volume":"95","author":"Skacel, M.","year":"2000","unstructured":"Skacel, M., R. E.Petras, and T. L.Gramlich. et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.Am J Gastroenterol2000. 95:3383\u20133387."},{"key":"i1543-2165-132-10-1577-b91","series-title":"Hum Pathol","first-page":"379","article-title":"Dysplasia as a predictive marker for invasive carcinoma in Barrett's esophagus: a follow-up study based on 138 cases from a diagnostic variability study.","volume":"32","author":"Montgomery, E.","year":"2001","unstructured":"Montgomery, E., J. R.Goldblum, and J. K.Greenson. et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett's esophagus: a follow-up study based on 138 cases from a diagnostic variability study.Hum Pathol2001. 32:379\u2013388."},{"key":"i1543-2165-132-10-1577-b92","series-title":"Gut","first-page":"486","article-title":"Can extent of high-grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?","volume":"52","author":"Dar, M. S.","year":"2003","unstructured":"Dar, M. S., J. R.Goldblum, and T. W.Rice. et al. Can extent of high-grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?Gut2003. 52:486\u2013489."},{"key":"i1543-2165-132-10-1577-b93","series-title":"Gastroenterology","first-page":"1212","article-title":"Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometric follow-up of a cohort.","volume":"102","author":"Reid, B. J.","year":"1992","unstructured":"Reid, B. J., P. L.Blount, C. E.Rubin, D. S.Levine, R. C.Haggitt, and P. S.Rabinovitch. Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometric follow-up of a cohort.Gastroenterology1992. 102:1212\u20131219."},{"key":"i1543-2165-132-10-1577-b94","series-title":"Cancer Res","first-page":"4495","article-title":"p53 gene mutations in Barrett's epithelium and esophageal cancer.","volume":"51","author":"Casson, A. G.","year":"1991","unstructured":"Casson, A. G., T.Mukhopadhay, K. R.Cleary, J. Y.Ro, B.Levin, and J. A.Roth. p53 gene mutations in Barrett's epithelium and esophageal cancer.Cancer Res1991. 51:4495\u20134499."},{"key":"i1543-2165-132-10-1577-b95","series-title":"Gastroenterology","first-page":"1012","article-title":"TP53 mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus.","volume":"107","author":"Haamelin, R.","year":"1994","unstructured":"Haamelin, R., J. F.Flejou, and F.Muzeau. et al. TP53 mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus.Gastroenterology1994. 107:1012\u20131018."},{"key":"i1543-2165-132-10-1577-b96","series-title":"Gastroenterology","first-page":"119","article-title":"Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.","volume":"105","author":"Reid, B. J.","year":"1993","unstructured":"Reid, B. J., C. A.Sanchez, P. L.Blount, and D. S.Levine. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.Gastroenterology1993. 105:119\u2013129."},{"key":"i1543-2165-132-10-1577-b97","series-title":"Gastrointest Endosc Clin North Am","first-page":"369","article-title":"Biomarkers in Barrett's esophagus.","volume":"13","author":"Reid, B. J.","year":"2003","unstructured":"Reid, B. J., P. L.Blount, and P. S.Rabinovitch. Biomarkers in Barrett's esophagus.Gastrointest Endosc Clin North Am2003. 13:369\u2013397."},{"key":"i1543-2165-132-10-1577-b98","series-title":"Am J Gastroenterol","first-page":"2508","article-title":"p53 Expression in low-grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.","volume":"97","author":"Skacel, M.","year":"2002","unstructured":"Skacel, M., R. E.Petras, and L. A.Rybicki. et al. p53 Expression in low-grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.Am J Gastroenterol2002. 97:2508\u20132513."},{"key":"i1543-2165-132-10-1577-b99","series-title":"Dig Dis Sci","first-page":"697","article-title":"p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia.","volume":"42","author":"Younes, M.","year":"1997","unstructured":"Younes, M., A.Ertan, and L. V.Lechago. et al. p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia.Dig Dis Sci1997. 42:697\u2013701."},{"key":"i1543-2165-132-10-1577-b100","series-title":"Cancer Res","first-page":"1561","article-title":"Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.","volume":"64","author":"McManus, D. T.","year":"2004","unstructured":"McManus, D. T., A.Olaru, and S. J.Meltzer. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.Cancer Res2004. 64:1561\u20131569."},{"key":"i1543-2165-132-10-1577-b101","series-title":"Am J Gastroenterol","first-page":"3440","article-title":"Management of Barrett's esophagus: a national study of practice patterns and their cost implications.","volume":"94","author":"Gross, G.","year":"1999","unstructured":"Gross, G., M.Canto, and J.Hixson. et al. Management of Barrett's esophagus: a national study of practice patterns and their cost implications.Am J Gastroenterol1999. 94:3440\u20133447."},{"key":"i1543-2165-132-10-1577-b102","series-title":"Ann Intern Med","first-page":"176","article-title":"Screening and surveillance for Barrett's esophagus in high-risk groups: a cost-utility analysis.","volume":"138","author":"Inadomi, J. M.","year":"2003","unstructured":"Inadomi, J. M., R.Sampliner, J.Lagergren, D.Leiberman, A. M.Fendrick, and N.Vakil. Screening and surveillance for Barrett's esophagus in high-risk groups: a cost-utility analysis.Ann Intern Med2003. 138:176\u2013186."},{"key":"i1543-2165-132-10-1577-b103","series-title":"Gastrointest Endosc","first-page":"197","article-title":"Practice patterns for surveillance of Barrett's esophagus in the United States.","volume":"52","author":"Falk, G.","year":"2000","unstructured":"Falk, G., T.Ours, and J.Richter. Practice patterns for surveillance of Barrett's esophagus in the United States.Gastrointest Endosc2000. 52:197\u2013203."},{"key":"i1543-2165-132-10-1577-b104","series-title":"Gastroenterology","first-page":"633","article-title":"Surveillance and survival in Barrett's adenocarcinomas: a population-based study.","volume":"122","author":"Corley, D. A.","year":"2002","unstructured":"Corley, D. A., T. R.Levin, L. A.Habel, N. S.Weiss, and P. A.Buffer. Surveillance and survival in Barrett's adenocarcinomas: a population-based study.Gastroenterology2002. 122:633\u2013640."},{"key":"i1543-2165-132-10-1577-b105","series-title":"J Thorac Cardiovasc Surg","first-page":"383","article-title":"Endoscopic surveillance of Barrett's esophagus: does it help?","volume":"105","author":"Strietz, J. M.","year":"1993","unstructured":"Strietz, J. M., C. W.Andrews, and F. H. JrEllis. Endoscopic surveillance of Barrett's esophagus: does it help?J Thorac Cardiovasc Surg1993. 105:383\u2013387."},{"key":"i1543-2165-132-10-1577-b106","series-title":"J Thorac Cardiovasc Surg","first-page":"813","article-title":"Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.","volume":"108","author":"Peters, J. H.","year":"1994","unstructured":"Peters, J. H., G. W. B.Clark, A. P.Ireland, P.Chandrasoma, T. C.Smyrk, and T. R.DeMeester. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.J Thorac Cardiovasc Surg1994. 108:813\u2013822."},{"key":"i1543-2165-132-10-1577-b107","series-title":"Am J Gastroenterol","first-page":"927","article-title":"Dysplasia in Barrett's esophagus: limitations of current management strategies.","volume":"100","author":"Spechler, S. J.","year":"2005","unstructured":"Spechler, S. J.\n          \n          Dysplasia in Barrett's esophagus: limitations of current management strategies.\n          Am J Gastroenterol\n          2005. 100:927\u2013935."},{"key":"i1543-2165-132-10-1577-b108","series-title":"Gastroenterology","first-page":"310","article-title":"A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.","volume":"127","author":"Sharma, P.","year":"2004","unstructured":"Sharma, P., K.McQuaid, and J.Dent. et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.Gastroenterology2004. 127:310\u2013330."},{"key":"i1543-2165-132-10-1577-b109","series-title":"Gastrointest Endosc","first-page":"760","article-title":"Ablation therapy for Barrett's esophagus.","volume":"58","author":"Eisen, G. M.","year":"2003","unstructured":"Eisen, G. M.\n          \n          Ablation therapy for Barrett's esophagus.\n          Gastrointest Endosc\n          2003. 58:760\u2013769."},{"key":"i1543-2165-132-10-1577-b110","series-title":"Clin Gastroenterol Hepatol","first-page":"258","article-title":"Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.","volume":"1","author":"Attwood, S. E. A.","year":"2003","unstructured":"Attwood, S. E. A., C. J.Lewis, S.Caplin, K.Hemming, and G.Armstrong. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.Clin Gastroenterol Hepatol2003. 1:258\u2013263."},{"key":"i1543-2165-132-10-1577-b111","series-title":"Nat Clin Pract Gastroenterol Hepatol","first-page":"323","article-title":"Technology insight: ablative techniques for Barrett's esophagus: current and emerging trends.","volume":"2","author":"Johnston, M. H.","year":"2005","unstructured":"Johnston, M. H.\n          \n          Technology insight: ablative techniques for Barrett's esophagus: current and emerging trends.\n          Nat Clin Pract Gastroenterol Hepatol\n          2005. 2:323\u2013330."},{"key":"i1543-2165-132-10-1577-b1","series-title":"Cancer","first-page":"676","article-title":"Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.","volume":"3","author":"Wild, C. P.","year":"2003","unstructured":"Wild, C. P. and L. J.Hardle. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.Cancer2003. 3:676\u2013684."},{"key":"i1543-2165-132-10-1577-b2","series-title":"Scand J Gastroenterol","first-page":"51","article-title":"Barrett's oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues.","volume":"35","author":"van Sandick, J. W.","year":"2001","unstructured":"van Sandick, J. W., J. J. B.van Lanschot, G. N. J.Tygat, G. J. A.Offerhaus, and H.Obertop. Barrett's oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues.Scand J Gastroenterol2001. 35:51\u201360."},{"key":"i1543-2165-132-10-1577-b3","series-title":"Int J Cancer","first-page":"860","article-title":"Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995.","volume":"99","author":"Vizcaino, A. P.","year":"2002","unstructured":"Vizcaino, A. P., V.Moreno, R.Lambert, and D. M.Perkin. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995.Int J Cancer2002. 99:860\u2013868."},{"key":"i1543-2165-132-10-1577-b4","series-title":"Cancer","first-page":"2049","article-title":"Changing patterns in the incidence of esophageal and gastric carcinomas in the United States.","volume":"3","author":"Devesa, S. S.","year":"1988","unstructured":"Devesa, S. S., W. J.Blot, and J. F.Fraumeni. Changing patterns in the incidence of esophageal and gastric carcinomas in the United States.Cancer1988. 3:2049\u20132053."},{"key":"i1543-2165-132-10-1577-b5","series-title":"Int J Epidemiol","first-page":"645","article-title":"Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.","volume":"29","author":"Botterweck, A. A. M.","year":"2000","unstructured":"Botterweck, A. A. M., L. J.Schouten, and A.Volovics. et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.Int J Epidemiol2000. 29:645\u2013654."},{"key":"i1543-2165-132-10-1577-b6","series-title":"Gastroenterology","first-page":"310","article-title":"A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.","volume":"127","author":"Sharma, P.","year":"2004","unstructured":"Sharma, P., K.McQuaid, and J.Dent. et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.Gastroenterology2004. 127:310\u2013330."},{"key":"i1543-2165-132-10-1577-b7","series-title":"Gastroenterology","first-page":"461","article-title":"Prevalence of Barrett's esophagus in asymptomatic individuals.","volume":"123","author":"Gerson, L. B.","year":"2002","unstructured":"Gerson, L. B., K.Shelter, and G.Triadafilopoulos. Prevalence of Barrett's esophagus in asymptomatic individuals.Gastroenterology2002. 123:461\u2013467."},{"key":"i1543-2165-132-10-1577-b8","series-title":"Gastroenterology","first-page":"1670","article-title":"Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.","volume":"125","author":"Rex, D. K.","year":"2003","unstructured":"Rex, D. K., O'W.Cummings, and M.Shaw. et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.Gastroenterology2003. 125:1670\u20131677."},{"issue":"1","key":"i1543-2165-132-10-1577-b9","series-title":"Cancer Cell","first-page":"11","article-title":"Focus on Barrett's esophagus and esophageal adenocarcinoma.","volume":"6","author":"Paulson, T. G.","year":"2004","unstructured":"Paulson, T. G. and B. J.Reid. Focus on Barrett's esophagus and esophageal adenocarcinoma.Cancer Cell2004. 61:11\u201316."},{"key":"i1543-2165-132-10-1577-b10","series-title":"Mod Pathol","first-page":"614","article-title":"The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventative strategies in Barrett's esophagus.","volume":"13","author":"Ormsby, A. H.","year":"2000","unstructured":"Ormsby, A. H., S. P.Kilgore, J. R.Goldblum, J. E.Richter, T. W.Rice, and T. L.Gramlich. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventative strategies in Barrett's esophagus.Mod Pathol2000. 13:614\u2013620."},{"key":"i1543-2165-132-10-1577-b11","series-title":"CA Cancer J Clin","first-page":"334","article-title":"Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.","volume":"55","author":"Souza, R. F.","year":"2005","unstructured":"Souza, R. F. and S. J.Spechler. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.CA Cancer J Clin2005. 55:334\u2013351."},{"key":"i1543-2165-132-10-1577-b12","series-title":"Gastroenterology","first-page":"1246","article-title":"Barrett's esophagus: development of dysplasia and adenocarcinoma.","volume":"96","author":"Hameetemen, W.","year":"1989","unstructured":"Hameetemen, W., G. N. J.Tytgat, H. J.Houthoff, and J. G.van den Tweel. Barrett's esophagus: development of dysplasia and adenocarcinoma.Gastroenterology1989. 96:1246\u20131256."},{"key":"i1543-2165-132-10-1577-b13","series-title":"Gastroenterology","first-page":"277","article-title":"Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.","volume":"116","author":"Hirota, W. K.","year":"1999","unstructured":"Hirota, W. K., T. N.Loughney, D. J.Lazas, C. L.Maydonovitch, V.Rholl, and R. K.Wong. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.Gastroenterology1999. 116:277\u2013285."},{"key":"i1543-2165-132-10-1577-b14","series-title":"Am J Gastroenterol","first-page":"788","article-title":"Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus.","volume":"103","year":"2008","unstructured":"Practice Parameters Committee of the American College of Gastroenterology.\n          \n          Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus.\n          Am J Gastroenterol\n          2008. 103:788\u2013797."},{"key":"i1543-2165-132-10-1577-b15","series-title":"Dig Dis Sci","first-page":"1537","article-title":"Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.","volume":"48","author":"Gopal, D. V.","year":"2003","unstructured":"Gopal, D. V., D. A.Lieberman, and N.Margaret. et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.Dig Dis Sci2003. 48:1537\u20131541."},{"key":"i1543-2165-132-10-1577-b16","series-title":"Am J Gastroenterol","first-page":"1930","article-title":"Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.","volume":"97","author":"Avidan, B.","year":"2002","unstructured":"Avidan, B., A.Sonnenberg, T. G.Schnell, G.Chejfec, A.Metz, and S. J.Sontag. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.Am J Gastroenterol2002. 97:1930\u20131936."},{"key":"i1543-2165-132-10-1577-b17","series-title":"Gastroenterology","first-page":"1212","article-title":"Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometry follow-up of a cohort.","volume":"102","author":"Reid, B. J.","year":"1992","unstructured":"Reid, B. J., P. L.Blount, C. E.Rubin, D. S.Levine, R. C.Haggitt, and P. S.Rabinovitch. Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometry follow-up of a cohort.Gastroenterology1992. 102:1212\u20131219."},{"key":"i1543-2165-132-10-1577-b18","series-title":"Gastroenterology","first-page":"1392","article-title":"The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M Criteria.","volume":"131","author":"Sharma, P.","year":"2006","unstructured":"Sharma, P., J.Dent, and D.Armstrong. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M Criteria.Gastroenterology2006. 131:1392\u20131399."},{"key":"i1543-2165-132-10-1577-b19","series-title":"Am J Surg Pathol","first-page":"183","article-title":"Surgical pathology of adenocarcinoma arising in Barrett's esophagus: analysis of 67 cases.","volume":"19","author":"Paraf, F.","year":"1995","unstructured":"Paraf, F., J. F.Flejou, and J. P.Pignon. et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus: analysis of 67 cases.Am J Surg Pathol1995. 19:183\u2013191."},{"key":"i1543-2165-132-10-1577-b20","series-title":"Am J Surg Pathol","first-page":"563","article-title":"The spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of 26 patients.","volume":"8","author":"Smith, R. R.","year":"1984","unstructured":"Smith, R. R., S. R.Hamilton, and J. K.Boitnott. et al. The spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of 26 patients.Am J Surg Pathol1984. 8:563\u2013573."},{"key":"i1543-2165-132-10-1577-b21","series-title":"Am J Gastroenterol","first-page":"1853","article-title":"Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.","volume":"100","author":"Odze, R. D.","year":"2005","unstructured":"Odze, R. D.\n          \n          Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.\n          Am J Gastroenterol\n          2005. 100:1853\u20131867."},{"key":"i1543-2165-132-10-1577-b22","series-title":"Am J Surg Pathol","first-page":"1442","article-title":"Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.","volume":"27","author":"Philips, R. W.","year":"2003","unstructured":"Philips, R. W., H. F.Frierson, and C. A.Moskaluk. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.Am J Surg Pathol2003. 27:1442\u20131447."},{"key":"i1543-2165-132-10-1577-b23","series-title":"Am J Surg Pathol","first-page":"978","article-title":"Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to CEA, CD10 and AFP.","volume":"26","author":"Chu, P. G.","year":"2002","unstructured":"Chu, P. G., S.Ishizawa, and E.Wu. et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to CEA, CD10 and AFP.Am J Surg Pathol2002. 26:978\u2013988."},{"key":"i1543-2165-132-10-1577-b24","series-title":"Biochem Cell Biol","first-page":"957","article-title":"Cdx1 and Cdx2 homeobox genes in the intestine.","volume":"7","author":"Freund, J. N.","year":"1998","unstructured":"Freund, J. N., C.Domon-Dell, and M.Kedinger. et al. Cdx1 and Cdx2 homeobox genes in the intestine.Biochem Cell Biol1998. 7:957\u2013969."},{"key":"i1543-2165-132-10-1577-b25","series-title":"Am J Surg Pathol","first-page":"1357","article-title":"Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.","volume":"27","author":"Glickman, J. N.","year":"2003","unstructured":"Glickman, J. N., A.Shahsafaei, and R. D.Odze. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.Am J Surg Pathol2003. 27:1357\u20131365."},{"key":"i1543-2165-132-10-1577-b26","series-title":"Am J Gastroenterol","first-page":"1375","article-title":"Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.","volume":"97","author":"Cameron, A. J.","year":"2002","unstructured":"Cameron, A. J., E. O.Souto, and T. C.Smyrk. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.Am J Gastroenterol2002. 97:1375\u20131380."},{"key":"i1543-2165-132-10-1577-b27","series-title":"Dis Esophagus","first-page":"287","article-title":"Adenocarcinoma of the esophagogastric junction: could the characteristics of adjacent intestinal metaplasia help in the understanding of biopathogenesis.","volume":"15","author":"Cabrera, R. A.","year":"2002","unstructured":"Cabrera, R. A., P.Chaves, and M.Crespo. et al. Adenocarcinoma of the esophagogastric junction: could the characteristics of adjacent intestinal metaplasia help in the understanding of biopathogenesis.Dis Esophagus2002. 15:287\u2013289."},{"key":"i1543-2165-132-10-1577-b28","series-title":"Gastroenterology","first-page":"264A","article-title":"Loss of goblet cell differentiation occurs with the progression of dysplasia in Barrett's esophagus.","volume":"130","author":"Srivastava, A.","year":"2006","unstructured":"Srivastava, A., J. L.Hornick, and X.Li. et al. Loss of goblet cell differentiation occurs with the progression of dysplasia in Barrett's esophagus.Gastroenterology2006. 130:(suppl 2). 264A."},{"key":"i1543-2165-132-10-1577-b29","series-title":"Dig Dis Sci","first-page":"2108","article-title":"Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy.","volume":"47","author":"Jones, T. F.","year":"2002","unstructured":"Jones, T. F., P.Sharma, and B.Daaboul. et al. Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy.Dig Dis Sci2002. 47:2108\u20132111."},{"key":"i1543-2165-132-10-1577-b30","series-title":"Am J Gastroenterol","first-page":"115","article-title":"Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.","volume":"102","author":"Harrison, R.","year":"2007","unstructured":"Harrison, R., I.Perry, and W.Haddadin. et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.Am J Gastroenterol2007. 102:115\u20131161."},{"key":"i1543-2165-132-10-1577-b31","series-title":"Ann Surg","first-page":"619","article-title":"Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.","volume":"234","author":"Oberg, S.","year":"2001","unstructured":"Oberg, S., J.Johansson, and J.Wenner. et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.Ann Surg2001. 234:619\u2013626."},{"key":"i1543-2165-132-10-1577-b32","series-title":"Lancet","first-page":"1711","article-title":"Cytokerin 7\/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia?","volume":"33","author":"Odze, R.","year":"2002","unstructured":"Odze, R.\n          \n          Cytokerin 7\/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia?\n          Lancet\n          2002. 33:1711\u20131713."},{"issue":"1","key":"i1543-2165-132-10-1577-b33","series-title":"Ann Diag Pathol","first-page":"67","article-title":"The significance and etiology of intestinal metaplasia of the esophagogastric junction.","volume":"61","author":"Goldblum, J. R.","year":"2002","unstructured":"Goldblum, J. R.\n          \n          The significance and etiology of intestinal metaplasia of the esophagogastric junction.\n          Ann Diag Pathol\n          2002. 611:67\u201373."},{"key":"i1543-2165-132-10-1577-b34","series-title":"Gastroenterology","first-page":"218","article-title":"The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.","volume":"117","author":"Spechler, S. J.","year":"1999","unstructured":"Spechler, S. J.\n          \n          The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.\n          Gastroenterology\n          1999. 117:218\u2013228."},{"key":"i1543-2165-132-10-1577-b35","series-title":"Am J Surg Pathol","first-page":"1733","article-title":"Morphological features are useful in distinguishing Barrett's esophagus from carditis with intestinal metaplasia.","volume":"31","author":"Srivastava, A.","year":"2007","unstructured":"Srivastava, A., R. D.Odze, G.Lauwers, M.Redston, D.Antonioli, and J. N.Glickman. Morphological features are useful in distinguishing Barrett's esophagus from carditis with intestinal metaplasia.Am J Surg Pathol2007. 31:1733\u20131741."},{"key":"i1543-2165-132-10-1577-b36","series-title":"Am J Surg Pathol","first-page":"960","article-title":"Pathologic features of reflux and Helicobacter pylori-associated carditis; a comparative study.","volume":"27","author":"Wieczorek, T.","year":"2003","unstructured":"Wieczorek, T., H.Wang, D.Antonioli, J.Glickman, and R.Odze. Pathologic features of reflux and Helicobacter pylori-associated carditis; a comparative study.Am J Surg Pathol2003. 27:960\u2013968."},{"key":"i1543-2165-132-10-1577-b37","series-title":"Hum Pathol","first-page":"1","article-title":"Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction.","volume":"30","author":"Chen, Y.","year":"1999","unstructured":"Chen, Y., H. H.Wang, and D. A.Antonioli. et al. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction.Hum Pathol1999. 30:1\u20138."},{"key":"i1543-2165-132-10-1577-b38","series-title":"Am J Surg Pathol","first-page":"1357","article-title":"The mucin core polypeptide pattern can help distinguish Barrett's esophagus (BE) from inflammation of the gastric cardia (carditis) with intestinal metaplasia.","volume":"27","author":"Glickman, J. N.","year":"2003","unstructured":"Glickman, J. N., A.Shahsafaei, and R. D.Odze. The mucin core polypeptide pattern can help distinguish Barrett's esophagus (BE) from inflammation of the gastric cardia (carditis) with intestinal metaplasia.Am J Surg Pathol2003. 27:1357\u20131365."},{"key":"i1543-2165-132-10-1577-b39","series-title":"Hum Pathol","first-page":"288","article-title":"Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.","volume":"30","author":"Ormsby, A. H.","year":"1999","unstructured":"Ormsby, A. H., J. R.Goldblum, and T. W.Rice. et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.Hum Pathol1999. 30:288\u2013294."},{"key":"i1543-2165-132-10-1577-b40","series-title":"Gastroenterology","first-page":"415A","article-title":"Interinstitutional variability in the interpretation of cytokeratin 7\/20 staining patterns in Barrett's esophagus.","volume":"120","author":"Glickman, J. N.","year":"2001","unstructured":"Glickman, J. N., A. H.Ormsby, T.Gramlich, J. R.Goldblum, and R. D.Odze. Interinstitutional variability in the interpretation of cytokeratin 7\/20 staining patterns in Barrett's esophagus.Gastroenterology2001. 120:415A."},{"key":"i1543-2165-132-10-1577-b41","series-title":"Mod Pathol","first-page":"611","article-title":"Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.","volume":"15","author":"Mohammed, I. A.","year":"2002","unstructured":"Mohammed, I. A., C. J.Streutker, and R. H.Riddell. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.Mod Pathol2002. 15:611\u2013616."},{"key":"i1543-2165-132-10-1577-b42","series-title":"Am J Gastroenterol","first-page":"1378","article-title":"Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.","volume":"96","author":"El-Zimaity, H. M. T.","year":"2001","unstructured":"El-Zimaity, H. M. T. and D. Y.Graham. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.Am J Gastroenterol2001. 96:1378\u20131382."},{"key":"i1543-2165-132-10-1577-b43","article-title":"Pathogenesis of columnar cell-lined (Barrett's) esophagus.","author":"Hamilton, S. R.","unstructured":"Hamilton, S. R.\n          \n          Pathogenesis of columnar cell-lined (Barrett's) esophagus.\n          In: Spechler SJ, Goyal RK, eds. Barrett's Esophagus. New York, NY: Elsevier; 1985: 29\u201337."},{"key":"i1543-2165-132-10-1577-b44","series-title":"Am J Surg Pathol","first-page":"344","article-title":"Definition of histopathologic changes in gastroesophageal reflux disease.","volume":"24","author":"Chandrasoma, P. T.","year":"2000","unstructured":"Chandrasoma, P. T., D. M.Lokuhetty, and T. R.DeMeester. et al. Definition of histopathologic changes in gastroesophageal reflux disease.Am J Surg Pathol2000. 24:344\u2013351."},{"key":"i1543-2165-132-10-1577-b45","series-title":"Am J Gastroenterol","first-page":"2514","article-title":"Cytokeratin and DAS-1 immunostaining reveal similarities among the cardiac mucosa, CIM and Barrett's esophagus.","volume":"97","author":"DeMeester, S. R.","year":"2002","unstructured":"DeMeester, S. R., K. S.Wickramasinghe, and R. V. N.Lord. et al. Cytokeratin and DAS-1 immunostaining reveal similarities among the cardiac mucosa, CIM and Barrett's esophagus.Am J Gastroenterol2002. 97:2514\u20132523."},{"key":"i1543-2165-132-10-1577-b46","series-title":"Science","first-page":"1568","article-title":"Gastric cancer originating from bone marrow-derived cells.","volume":"306","author":"Houghton, J. M.","year":"2004","unstructured":"Houghton, J. M., C.Stoicov, and S.Nomura. et al. Gastric cancer originating from bone marrow-derived cells.Science2004. 306:1568\u20131571."},{"key":"i1543-2165-132-10-1577-b47","series-title":"Curr Opin Cell Biol","first-page":"740","article-title":"Epithelial-mesenchymal transitions in development and pathologies.","volume":"15","author":"Thiery, J. P.","year":"2003","unstructured":"Thiery, J. P.\n          \n          Epithelial-mesenchymal transitions in development and pathologies.\n          Curr Opin Cell Biol\n          2003. 15:740\u2013746."},{"key":"i1543-2165-132-10-1577-b48","series-title":"Br J Surg","first-page":"113","article-title":"Experimental columnar metaplasia in the canine oesophagus.","volume":"75","author":"Gillen, P.","year":"1988","unstructured":"Gillen, P., P.Keeling, P. J.Byrne, A. B.West, and T. P.Hennessy. Experimental columnar metaplasia in the canine oesophagus.Br J Surg1988. 75:113\u2013115."},{"key":"i1543-2165-132-10-1577-b49","series-title":"Surgery","first-page":"17","article-title":"Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus.","volume":"115","author":"Li, H.","year":"1994","unstructured":"Li, H., T. N.Walsh, and G.O'Dowd. et al. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus.Surgery1994. 115:17\u201381."},{"key":"i1543-2165-132-10-1577-b50","series-title":"J Thorac Cardiovasc Surg","first-page":"13","article-title":"The lower esophagus lined by columnar epithelium: its association with hiatal hernia, ulcer stricture, and tumor.","volume":"45","author":"Adler, R. H.","year":"1963","unstructured":"Adler, R. H.\n          \n          The lower esophagus lined by columnar epithelium: its association with hiatal hernia, ulcer stricture, and tumor.\n          J Thorac Cardiovasc Surg\n          1963. 45:13\u201332."},{"key":"i1543-2165-132-10-1577-b51","series-title":"Am J Surg Pathol","first-page":"569","article-title":"Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus.","volume":"25","author":"Glickman, J. N.","year":"2001","unstructured":"Glickman, J. N., Y. Y.Chen, and H. H.Wang. et al. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus.Am J Surg Pathol2001. 25:569\u2013578."},{"key":"i1543-2165-132-10-1577-b52","series-title":"Am J Gastroenterol","first-page":"3268","article-title":"Prospective evaluation of multilayered epithelium in Barrett's esophagus.","volume":"96","author":"Shields, H.","year":"201","unstructured":"Shields, H., S. J.Rosenberg, and F. R.Zwas. et al. Prospective evaluation of multilayered epithelium in Barrett's esophagus.Am J Gastroenterol201. 96:3268\u20133273."},{"key":"i1543-2165-132-10-1577-b53","series-title":"Mod Pathol","first-page":"103A","article-title":"Multilayered epithelium at the squamocolumnar junction is a histological marker for gastroesophageal reflux disease.","volume":"81","author":"Glickman, J. N.","year":"2005","unstructured":"Glickman, J. N., S. J.Spechler, and T.Dineen. et al. Multilayered epithelium at the squamocolumnar junction is a histological marker for gastroesophageal reflux disease.Mod Pathol2005. 81:(suppl 1). 103A."},{"key":"i1543-2165-132-10-1577-b54","series-title":"J Clin Pathol","first-page":"1029","article-title":"Diagnosis and grading of dysplasia in Barrett's oesophagus.","volume":"59","author":"Odze, R. D.","year":"2006","unstructured":"Odze, R. D.\n          \n          Diagnosis and grading of dysplasia in Barrett's oesophagus.\n          J Clin Pathol\n          2006. 59:1029\u20131038."},{"key":"i1543-2165-132-10-1577-b55","series-title":"Hum Pathol","first-page":"931","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical information.","volume":"14","author":"Riddell, R. H.","year":"1983","unstructured":"Riddell, R. H., H.Goldman, and D. E.Ransohoff. et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical information.Hum Pathol1983. 14:931\u2013968."},{"key":"i1543-2165-132-10-1577-b56","series-title":"Gastroenterology","first-page":"1606","article-title":"Long-term surgical management of Barrett's esophagus with high-grade dysplasia.","volume":"120","author":"Schnell, T. G.","year":"2001","unstructured":"Schnell, T. G., S. J.Sontag, and G.Chejfec. et al. Long-term surgical management of Barrett's esophagus with high-grade dysplasia.Gastroenterology2001. 120:1606\u20131619."},{"key":"i1543-2165-132-10-1577-b57","series-title":"Gut","first-page":"251","article-title":"The Vienna classification of gastrointestinal epithelial neoplasia.","volume":"47","author":"Schlemper, R. J.","year":"200","unstructured":"Schlemper, R. J., R. H.Riddell, and Y.Kato. et al. The Vienna classification of gastrointestinal epithelial neoplasia.Gut200. 47:251\u2013255."},{"key":"i1543-2165-132-10-1577-b58","series-title":"Nat Genet","first-page":"106","article-title":"Evolution of neoplastic cell lineages in Barrett's oesophagus.","volume":"22","author":"Barrett, M. T.","year":"1999","unstructured":"Barrett, M. T., C. A.Sanchez, and L. J.Prevo. et al. Evolution of neoplastic cell lineages in Barrett's oesophagus.Nat Genet1999. 22:106\u2013109."},{"key":"i1543-2165-132-10-1577-b59","series-title":"Nat Genet","first-page":"468","article-title":"Genetic clonal diversity predicts progression to esophageal adenocarcinoma.","volume":"38","author":"Maley, C. C.","year":"2006","unstructured":"Maley, C. C., P. C.Galipeau, and J. C.Finley. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma.Nat Genet2006. 38:468\u2013473."},{"key":"i1543-2165-132-10-1577-b60","series-title":"Semin Cancer Biol","first-page":"474","article-title":"Natural selection in neoplastic progression of Barrett's esophagus.","volume":"15","author":"Maley, C. C.","year":"2005","unstructured":"Maley, C. C. and B. J.Reid. Natural selection in neoplastic progression of Barrett's esophagus.Semin Cancer Biol2005. 15:474\u2013483."},{"key":"i1543-2165-132-10-1577-b61","series-title":"Can Res","first-page":"3414","article-title":"Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.","volume":"64","author":"Maley, C. C.","year":"2004","unstructured":"Maley, C. C., P. C.Galipeau, and X.Li. et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.Can Res2004. 64:3414\u20133427."},{"key":"i1543-2165-132-10-1577-b62","series-title":"Hum Pathol","first-page":"412","article-title":"Proliferative characteristics of intestinalized mucosa win the distal esophagus and gastroesophageal junction (short segment Barrett's esophagus).","volume":"30","author":"Gulizia, J.","year":"1999","unstructured":"Gulizia, J., H.Wang, and D.Antonioli. et al. Proliferative characteristics of intestinalized mucosa win the distal esophagus and gastroesophageal junction (short segment Barrett's esophagus).Hum Pathol1999. 30:412\u2013419."},{"key":"i1543-2165-132-10-1577-b63","series-title":"Cancer Res","first-page":"8284","article-title":"p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.","volume":"61","author":"Wong, D. J.","year":"2001","unstructured":"Wong, D. J., T. G.Paulon, and L. J.Prevo. et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.Cancer Res2001. 61:8284\u20138289."},{"key":"i1543-2165-132-10-1577-b64","series-title":"Mod Pathol","first-page":"788","article-title":"Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved.","volume":"20","author":"Chaves, P.","year":"2007","unstructured":"Chaves, P., M.Crespo, and C.Ribeiro. et al. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved.Mod Pathol2007. 20:788\u2013796."},{"key":"i1543-2165-132-10-1577-b65","series-title":"Lab Invest","first-page":"466","article-title":"High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.","volume":"87","author":"Yu, C.","year":"2007","unstructured":"Yu, C., X.Zhang, and Q.Huang. et al. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.Lab Invest2007. 87:466\u2013472."},{"key":"i1543-2165-132-10-1577-b66","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"559","article-title":"p53 is frequently mutated in Barrett's metaplasia of the intestinal type.","volume":"5","author":"Campomenosi, P.","year":"1996","unstructured":"Campomenosi, P., M.Conio, and M.Bogliolo. et al. p53 is frequently mutated in Barrett's metaplasia of the intestinal type.Cancer Epidemiol Biomarkers Prev1996. 5:559\u2013565."},{"key":"i1543-2165-132-10-1577-b67","series-title":"Hum Pathol","first-page":"368","article-title":"Reproducibility of the diagnosis if dysplasia in Barrett's esophagus: a reaffirmation.","volume":"32","author":"Montgomery, E.","year":"2001","unstructured":"Montgomery, E., M. P.Bronner, and J. R.Goldblum. et al. Reproducibility of the diagnosis if dysplasia in Barrett's esophagus: a reaffirmation.Hum Pathol2001. 32:368\u2013378."},{"key":"i1543-2165-132-10-1577-b68","series-title":"Hum Pathol","first-page":"166","article-title":"Observer variation in the diagnosis of dysplasia in Barrett's esophagus.","volume":"19","author":"Reid, B. J.","year":"1988","unstructured":"Reid, B. J., R. C.Haggitt, and C. E.Rubin. et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.Hum Pathol1988. 19:166\u2013178."},{"key":"i1543-2165-132-10-1577-b69","series-title":"Histopathology","first-page":"920","article-title":"Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.","volume":"50","author":"Kerkhof, M.","year":"2007","unstructured":"Kerkhof, M., H.van Dekken, and E. W.Steyerberg. et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.Histopathology2007. 50:920\u2013927."},{"key":"i1543-2165-132-10-1577-b70","series-title":"Am J Surg Pathol","first-page":"423","article-title":"Crypt dysplasia with surface maturation: a clinical, pathologic and molecular study of a Barrett's esophagus cohort.","volume":"30","author":"Lomo, L.","year":"2006","unstructured":"Lomo, L., P. L.Blount, and C. A.Sanchez. et al. Crypt dysplasia with surface maturation: a clinical, pathologic and molecular study of a Barrett's esophagus cohort.Am J Surg Pathol2006. 30:423\u2013435."},{"key":"i1543-2165-132-10-1577-b71","series-title":"Lab Invest","first-page":"133A","article-title":"High fidelity image cytometry in neoplastic lesions in Barrett's esophagus, including basal crypt dysplasia-like atypia with surface maturation.","volume":"87","author":"Zhang, X.","year":"2007","unstructured":"Zhang, X., R.Goyal, Q.Huang, and RdOdze. High fidelity image cytometry in neoplastic lesions in Barrett's esophagus, including basal crypt dysplasia-like atypia with surface maturation.Lab Invest2007. 87:(suppl 1). 133A."},{"key":"i1543-2165-132-10-1577-b72","series-title":"Ann Thorac Surg","first-page":"787","article-title":"Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.","volume":"65","author":"Rice, T. W.","year":"1998","unstructured":"Rice, T. W., G. JrZuccaro, and D. J.Adelstein. et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.Ann Thorac Surg1998. 65:787\u2013792."},{"key":"i1543-2165-132-10-1577-b73","series-title":"Gut","first-page":"671","article-title":"Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.","volume":"51","author":"Ormsby, A. H.","year":"2002","unstructured":"Ormsby, A. H., R. I.Petros, and W. H.Henricks. et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.Gut2002. 51:671\u2013676."},{"key":"i1543-2165-132-10-1577-b74","series-title":"Cancer","first-page":"423","article-title":"Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.","volume":"75","author":"Hong, M. K.","year":"1995","unstructured":"Hong, M. K., W. B.Laskin, and B. E.Herman. et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.Cancer1995. 75:423\u2013429."},{"key":"i1543-2165-132-10-1577-b75","series-title":"Dis Esophagus","first-page":"322","article-title":"Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.","volume":"17","author":"Feith, M.","year":"2004","unstructured":"Feith, M., H. J.Stein, and J.Mueller. et al. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.Dis Esophagus2004. 17:322\u2013327."},{"key":"i1543-2165-132-10-1577-b76","series-title":"J Natl Cancer Inst","first-page":"1316","article-title":"Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.","volume":"92","author":"Bani-Hani, K.","year":"200","unstructured":"Bani-Hani, K., I. G.Martin, and L. J.Hardie. et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.J Natl Cancer Inst200. 92:1316\u20131321."},{"key":"i1543-2165-132-10-1577-b77","series-title":"Ann Surg","first-page":"17","article-title":"Barrett's esophagus: the significance of p53 in clinical practice.","volume":"225","author":"Ireland, A. P.","year":"1997","unstructured":"Ireland, A. P., G. W. B.Clark, and T. R.DeMeester. Barrett's esophagus: the significance of p53 in clinical practice.Ann Surg1997. 225:17\u201330."},{"key":"i1543-2165-132-10-1577-b78","series-title":"Gastroenterology","first-page":"1220","article-title":"Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.","volume":"102","author":"Ramel, S.","year":"1992","unstructured":"Ramel, S., B. J.Reid, and C. A.Sanchez. et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.Gastroenterology1992. 102:1220\u20131228."},{"key":"i1543-2165-132-10-1577-b79","series-title":"Am J Surg Pathol","first-page":"871","article-title":"AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis and Crohn's disease.","volume":"30","author":"Dorer, R.","year":"2006","unstructured":"Dorer, R. and R. D.Odze. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis and Crohn's disease.Am J Surg Pathol2006. 30:871\u2013877."},{"key":"i1543-2165-132-10-1577-b80","series-title":"Hum Pathol","first-page":"1601","article-title":"Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.","volume":"37","author":"Lisovsky, M.","year":"2006","unstructured":"Lisovsky, M., O.Falkowski, and T.Bhuiya. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.Hum Pathol2006. 37:1601\u20131606."},{"key":"i1543-2165-132-10-1577-b81","series-title":"Am J Gastroenterol","first-page":"1657","article-title":"Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.","volume":"99","author":"Weston, A. P.","year":"2004","unstructured":"Weston, A. P., P.Sharma, and S.Mathur. et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.Am J Gastroenterol2004. 99:1657\u20131666."},{"key":"i1543-2165-132-10-1577-b82","series-title":"Am J Gastroenterol","first-page":"1669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.","volume":"95","author":"Reid, B. J.","year":"2000","unstructured":"Reid, B. J., D. S.Levine, and G.Longton. et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.Am J Gastroenterol2000. 95:1669\u20131676."},{"key":"i1543-2165-132-10-1577-b83","series-title":"Gastroenterology","first-page":"1630","article-title":"Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.","volume":"120","author":"Buttar, N. S.","year":"2001","unstructured":"Buttar, N. S., K. K.Wang, and T. J.Sebo. et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.Gastroenterology2001. 120:1630\u20131639."},{"key":"i1543-2165-132-10-1577-b84","series-title":"Am J Gastroenterol","first-page":"27","article-title":"Are ulcers a marker for invasive carcinoma in Barrett's esophagus?: data from a diagnostic variability study with clinical follow-up.","volume":"97","author":"Montgomery, E.","year":"2002","unstructured":"Montgomery, E., M. P.Bronner, and J. K.Greenson. et al. Are ulcers a marker for invasive carcinoma in Barrett's esophagus?: data from a diagnostic variability study with clinical follow-up.Am J Gastroenterol2002. 97:27\u201331."},{"key":"i1543-2165-132-10-1577-b85","series-title":"Am J Gastroenterol","first-page":"1888","article-title":"Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.","volume":"97","author":"Sampler, R. E.","year":"2002","unstructured":"Sampler, R. E.\n          \n          Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.\n          Am J Gastroenterol\n          2002. 97:1888\u20131895."},{"key":"i1543-2165-132-10-1577-b86","series-title":"Am J Gastroenterol","first-page":"1355","article-title":"p53 protein over expression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.","volume":"96","author":"Weston, A. P.","year":"2001","unstructured":"Weston, A. P., S. K.Banerjee, P.Sharma, T. M.Tran, R.Richards, and R.Cherian. p53 protein over expression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.Am J Gastroenterol2001. 96:1355\u20131362."},{"key":"i1543-2165-132-10-1577-b87","series-title":"Clin Gastroenterol Hepatol","first-page":"566","article-title":"Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.","volume":"4","author":"Sharma, P.","year":"2006","unstructured":"Sharma, P., G. W.Falk, and A. P.Weston. et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.Clin Gastroenterol Hepatol2006. 4:566\u2013572."},{"key":"i1543-2165-132-10-1577-b88","series-title":"Am J Gastroenterol","first-page":"1931","article-title":"Long-term endoscopic surveillance of patients with Barrett's esophagus: incidence of dysplasia and adenocarcinoma: a prospective study.","volume":"98","author":"Conio, M.","year":"2003","unstructured":"Conio, M., S.Blanchi, and G.Lapertoso. et al. Long-term endoscopic surveillance of patients with Barrett's esophagus: incidence of dysplasia and adenocarcinoma: a prospective study.Am J Gastroenterol2003. 98:1931\u20131939."},{"key":"i1543-2165-132-10-1577-b89","series-title":"Am J Gastroenterol","first-page":"483","article-title":"Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.","volume":"102","author":"Srivastava, A.","year":"2007","unstructured":"Srivastava, A., J. L.Hornick, and X.Li. et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.Am J Gastroenterol2007. 102:483\u2013493."},{"key":"i1543-2165-132-10-1577-b90","series-title":"Am J Gastroenterol","first-page":"3383","article-title":"The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.","volume":"95","author":"Skacel, M.","year":"2000","unstructured":"Skacel, M., R. E.Petras, and T. L.Gramlich. et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.Am J Gastroenterol2000. 95:3383\u20133387."},{"key":"i1543-2165-132-10-1577-b91","series-title":"Hum Pathol","first-page":"379","article-title":"Dysplasia as a predictive marker for invasive carcinoma in Barrett's esophagus: a follow-up study based on 138 cases from a diagnostic variability study.","volume":"32","author":"Montgomery, E.","year":"2001","unstructured":"Montgomery, E., J. R.Goldblum, and J. K.Greenson. et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett's esophagus: a follow-up study based on 138 cases from a diagnostic variability study.Hum Pathol2001. 32:379\u2013388."},{"key":"i1543-2165-132-10-1577-b92","series-title":"Gut","first-page":"486","article-title":"Can extent of high-grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?","volume":"52","author":"Dar, M. S.","year":"2003","unstructured":"Dar, M. S., J. R.Goldblum, and T. W.Rice. et al. Can extent of high-grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?Gut2003. 52:486\u2013489."},{"key":"i1543-2165-132-10-1577-b93","series-title":"Gastroenterology","first-page":"1212","article-title":"Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometric follow-up of a cohort.","volume":"102","author":"Reid, B. J.","year":"1992","unstructured":"Reid, B. J., P. L.Blount, C. E.Rubin, D. S.Levine, R. C.Haggitt, and P. S.Rabinovitch. Predictors of progression to malignancy in Barrett's esophagus: endoscopic histologic and flow cytometric follow-up of a cohort.Gastroenterology1992. 102:1212\u20131219."},{"key":"i1543-2165-132-10-1577-b94","series-title":"Cancer Res","first-page":"4495","article-title":"p53 gene mutations in Barrett's epithelium and esophageal cancer.","volume":"51","author":"Casson, A. G.","year":"1991","unstructured":"Casson, A. G., T.Mukhopadhay, K. R.Cleary, J. Y.Ro, B.Levin, and J. A.Roth. p53 gene mutations in Barrett's epithelium and esophageal cancer.Cancer Res1991. 51:4495\u20134499."},{"key":"i1543-2165-132-10-1577-b95","series-title":"Gastroenterology","first-page":"1012","article-title":"TP53 mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus.","volume":"107","author":"Haamelin, R.","year":"1994","unstructured":"Haamelin, R., J. F.Flejou, and F.Muzeau. et al. TP53 mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus.Gastroenterology1994. 107:1012\u20131018."},{"key":"i1543-2165-132-10-1577-b96","series-title":"Gastroenterology","first-page":"119","article-title":"Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.","volume":"105","author":"Reid, B. J.","year":"1993","unstructured":"Reid, B. J., C. A.Sanchez, P. L.Blount, and D. S.Levine. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.Gastroenterology1993. 105:119\u2013129."},{"key":"i1543-2165-132-10-1577-b97","series-title":"Gastrointest Endosc Clin North Am","first-page":"369","article-title":"Biomarkers in Barrett's esophagus.","volume":"13","author":"Reid, B. J.","year":"2003","unstructured":"Reid, B. J., P. L.Blount, and P. S.Rabinovitch. Biomarkers in Barrett's esophagus.Gastrointest Endosc Clin North Am2003. 13:369\u2013397."},{"key":"i1543-2165-132-10-1577-b98","series-title":"Am J Gastroenterol","first-page":"2508","article-title":"p53 Expression in low-grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.","volume":"97","author":"Skacel, M.","year":"2002","unstructured":"Skacel, M., R. E.Petras, and L. A.Rybicki. et al. p53 Expression in low-grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.Am J Gastroenterol2002. 97:2508\u20132513."},{"key":"i1543-2165-132-10-1577-b99","series-title":"Dig Dis Sci","first-page":"697","article-title":"p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia.","volume":"42","author":"Younes, M.","year":"1997","unstructured":"Younes, M., A.Ertan, and L. V.Lechago. et al. p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia.Dig Dis Sci1997. 42:697\u2013701."},{"key":"i1543-2165-132-10-1577-b100","series-title":"Cancer Res","first-page":"1561","article-title":"Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.","volume":"64","author":"McManus, D. T.","year":"2004","unstructured":"McManus, D. T., A.Olaru, and S. J.Meltzer. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.Cancer Res2004. 64:1561\u20131569."},{"key":"i1543-2165-132-10-1577-b101","series-title":"Am J Gastroenterol","first-page":"3440","article-title":"Management of Barrett's esophagus: a national study of practice patterns and their cost implications.","volume":"94","author":"Gross, G.","year":"1999","unstructured":"Gross, G., M.Canto, and J.Hixson. et al. Management of Barrett's esophagus: a national study of practice patterns and their cost implications.Am J Gastroenterol1999. 94:3440\u20133447."},{"key":"i1543-2165-132-10-1577-b102","series-title":"Ann Intern Med","first-page":"176","article-title":"Screening and surveillance for Barrett's esophagus in high-risk groups: a cost-utility analysis.","volume":"138","author":"Inadomi, J. M.","year":"2003","unstructured":"Inadomi, J. M., R.Sampliner, J.Lagergren, D.Leiberman, A. M.Fendrick, and N.Vakil. Screening and surveillance for Barrett's esophagus in high-risk groups: a cost-utility analysis.Ann Intern Med2003. 138:176\u2013186."},{"key":"i1543-2165-132-10-1577-b103","series-title":"Gastrointest Endosc","first-page":"197","article-title":"Practice patterns for surveillance of Barrett's esophagus in the United States.","volume":"52","author":"Falk, G.","year":"2000","unstructured":"Falk, G., T.Ours, and J.Richter. Practice patterns for surveillance of Barrett's esophagus in the United States.Gastrointest Endosc2000. 52:197\u2013203."},{"key":"i1543-2165-132-10-1577-b104","series-title":"Gastroenterology","first-page":"633","article-title":"Surveillance and survival in Barrett's adenocarcinomas: a population-based study.","volume":"122","author":"Corley, D. A.","year":"2002","unstructured":"Corley, D. A., T. R.Levin, L. A.Habel, N. S.Weiss, and P. A.Buffer. Surveillance and survival in Barrett's adenocarcinomas: a population-based study.Gastroenterology2002. 122:633\u2013640."},{"key":"i1543-2165-132-10-1577-b105","series-title":"J Thorac Cardiovasc Surg","first-page":"383","article-title":"Endoscopic surveillance of Barrett's esophagus: does it help?","volume":"105","author":"Strietz, J. M.","year":"1993","unstructured":"Strietz, J. M., C. W.Andrews, and F. H. JrEllis. Endoscopic surveillance of Barrett's esophagus: does it help?J Thorac Cardiovasc Surg1993. 105:383\u2013387."},{"key":"i1543-2165-132-10-1577-b106","series-title":"J Thorac Cardiovasc Surg","first-page":"813","article-title":"Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.","volume":"108","author":"Peters, J. H.","year":"1994","unstructured":"Peters, J. H., G. W. B.Clark, A. P.Ireland, P.Chandrasoma, T. C.Smyrk, and T. R.DeMeester. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.J Thorac Cardiovasc Surg1994. 108:813\u2013822."},{"key":"i1543-2165-132-10-1577-b107","series-title":"Am J Gastroenterol","first-page":"927","article-title":"Dysplasia in Barrett's esophagus: limitations of current management strategies.","volume":"100","author":"Spechler, S. J.","year":"2005","unstructured":"Spechler, S. J.\n          \n          Dysplasia in Barrett's esophagus: limitations of current management strategies.\n          Am J Gastroenterol\n          2005. 100:927\u2013935."},{"key":"i1543-2165-132-10-1577-b108","series-title":"Gastroenterology","first-page":"310","article-title":"A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.","volume":"127","author":"Sharma, P.","year":"2004","unstructured":"Sharma, P., K.McQuaid, and J.Dent. et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.Gastroenterology2004. 127:310\u2013330."},{"key":"i1543-2165-132-10-1577-b109","series-title":"Gastrointest Endosc","first-page":"760","article-title":"Ablation therapy for Barrett's esophagus.","volume":"58","author":"Eisen, G. M.","year":"2003","unstructured":"Eisen, G. M.\n          \n          Ablation therapy for Barrett's esophagus.\n          Gastrointest Endosc\n          2003. 58:760\u2013769."},{"key":"i1543-2165-132-10-1577-b110","series-title":"Clin Gastroenterol Hepatol","first-page":"258","article-title":"Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.","volume":"1","author":"Attwood, S. E. A.","year":"2003","unstructured":"Attwood, S. E. A., C. J.Lewis, S.Caplin, K.Hemming, and G.Armstrong. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.Clin Gastroenterol Hepatol2003. 1:258\u2013263."},{"key":"i1543-2165-132-10-1577-b111","series-title":"Nat Clin Pract Gastroenterol Hepatol","first-page":"323","article-title":"Technology insight: ablative techniques for Barrett's esophagus: current and emerging trends.","volume":"2","author":"Johnston, M. H.","year":"2005","unstructured":"Johnston, M. H.\n          \n          Technology insight: ablative techniques for Barrett's esophagus: current and emerging trends.\n          Nat Clin Pract Gastroenterol Hepatol\n          2005. 2:323\u2013330."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/132\/10\/article-p1577.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/132\/10\/1577\/2763772\/1543-2165(2008)132%255b1577_uotdat%255d2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/132\/10\/article-p1577.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/132\/10\/article-p1577.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:01:56Z","timestamp":1770771716000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/132\/10\/article-p1577.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":222,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.5858\/2008-132-1577-uotdat","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}